i
HIV prevention among injecting drug users: responses in developing and transitional countries.
-
Jun 1998
Source: Public Health Rep. 113(Suppl 1):170-181
[PDF-2.07 MB]
Details:
-
Alternative Title:Public Health Rep
-
Personal Author:
-
Description:Human immunodeficiency virus (HIV) infection associated with injecting drug use has been reported in at least 98 countries and territories worldwide. There is evidence that new epidemics are emerging in different regions, including Eastern Europe, Latin American, and the eastern Mediterranean. The authors provide a global overview of the situation of HIV infection associated with injecting drug use and responses that have been implemented in various developing and transitional countries.|Although there has been extensive documentation of the extent and nature of of HIV infection associated with injecting drug use in many developed countries and the various interventions implemented in those countries, there is very limited information on the situation in developing and transitional countries. This chapter brings together information from a broad range of sources, including published literature; "gray" or "fugitive" literature; data collected by the World Health Organization (WHO), the Joint United Nations Programme on HIV/AIDS (UNAIDS) and the United Nations International Drug Control Programme (UNDCP); personal communications; and direct observation by the authors. The authors have traveled extensively to a wide range of developing and transitional countries and have accessed information not readily available to the international research community.|A wide range of HIV prevention strategies targeting injecting drug users (IDUs) has been implemented in developing countries and countries in transition. Interventions include opioid substitution pharmacotherapy, needle syringe exchange and distribution, condom and bleach distribution, outreach to IDUs, peer education programs, and social network interventions. In some communities, completely new models of intervention and service delivery have developed in response to specific local needs and limitations.|Although empirical data may currently be lacking to demonstrate the effectiveness of may HIV prevention programs targeting IDUs in developing and transitional countries, there is evidence that innovative HIV prevention initiatives are being implemented and sustained in a wide range of sociocultural settings.
-
Subjects:
-
Pubmed ID:9722822
-
Pubmed Central ID:PMCnull
-
Document Type:
-
Collection(s):
-
Main Document Checksum:urn:sha256:bb067171f029916df3573efdbab14a8839dc567542827baed14080083fd11187
-
Download URL:
-
File Type:
Supporting Files
-
No Additional Files
More +
Related Documents
-
Personal Author:Singer, M ;Baer, H A...06/01/1998 | Public Health Rep. 113(Suppl 1):81-89Description:To break the link between drug use and the human immunodeficiency virus (HIV), in 1992 the state of Connecticut rescinded a 14-year ban on pharmacy sa...Personal Author:Cottler, L B ;Compton, W M...06/01/1998 | Public Health Rep. 113(Suppl 1):31-41Description:The purpose of this chapter is to describe the results of a randomized study (funded by the National Institute on Drug Abuse [NIDA]) comparing a peer-...Personal Author:Kumar, M S ;Mudaliar, S...06/01/1998 | Public Health Rep. 113(Suppl 1):58-66Description:Community-based outreach to drug injectors is an important component of human immunodeficiency virus (HIV) prevention strategy. The purpose of this ch...Personal Author:Coyle, S L ;Needle, R H...06/01/1998 | Public Health Rep. 113(Suppl 1):19-30Description:Over the past decade, a body of observational research has accrued about the effects of outreach-based human immunodeficiency virus (HIV) intervention...Personal Author:Levy, J A ;Fox, S EJun 1998 | Public Health Rep. 113(Suppl 1):160-169Description:This analysis describes the Outreach-Assisted Model of Partner Notification, an innovative strategy for encouraging seropositive injecting drug users ...Personal Author:Metzger, D S ;Navaline, H...Jun 1998 | Public Health Rep. 113(Suppl 1):97-106Description:As the acquired immunodeficiency syndrome (AIDS) epidemic among drug users enters its third decade in the United States, it is important to consider t...Personal Author:Broadhead, R S ;Heckathorn, D D...Jun 1998 | Public Health Rep. 113(Suppl 1):42-57Description:Since 1985, community outreach efforts to combat acquired immunodeficiency syndrome (AIDS) among injecting drug users (IDUs) in the United States have...Personal Author:Vlahov, D ;Junge, BJun 1998 | Public Health Rep. 113(Suppl 1):75-80Description:Injecting drug users (IDUs) are at high risk for infection by human immunodeficiency virus (HIV) and other blood-borne pathogens. In the United States...Personal Author:Des Jarlais, D C ;Friedman, S RJun 1998 | Public Health Rep. 113(Suppl 1):182-188Description:Acquired immunodeficiency syndrome (AIDS) was formally identified among injecting drug users (IDUs) in 1981, and research on preventing human immunode...Personal Author:Shriver, M ;de Burger, R...Jun 1998 | Public Health Rep. 113(Suppl 1):189-193Description:Five policy advocates and practitioners provide recommendations to researchers to make research data more usable, accessible, and applicable for the f...Personal Author:Booth, R E ;Kwiatkowski, C...Jun 1998 | Public Health Rep. 113(Suppl 1):116-128Description:High risk injection practices are common among injecting drug users (IDUs), even following intervention efforts. Moreover, relapse to risk behaviors h...Personal Author:Brooner, R ;Kidorf, M...Jun 1998 | Public Health Rep. 113(Suppl 1):129-139Description:Although lowering incidence rates of human immunodeficiency virus (HIV) transmission is the primary goal of needle exchange programs (NEPs), other des...Personal Author:Hartel, D M ;Schoenbaum, E EJun 1998 | Public Health Rep. 113(Suppl 1):107-115Description:We undertook a study of the role of methadone maintenance in protecting injecting drug users (IDUs) from human immunodeficiency virus (HIV) infection ...Personal Author:Valente, T W ;Foreman, R K...Jun 1998 | Public Health Rep. 113(Suppl 1):90-96Description:Our first objective was to develop an index of satellite exchange and then determine whether satellite exchangers (SEs) differed demographically or be...Personal Author:Latkin, C AJun 1998 | Public Health Rep. 113(Suppl 1):151-159Description:Guided by a social influence and empowerment framework, peer leaders in the injecting drug user (IDU) community were trained to promote human immunode...
More +
You May Also Like
Checkout today's featured content at stacks.cdc.gov